“DUAL-PATHWAY INHIBITION VS VEGF INHIBITION ALONE: A CLINICALCOMPARISON OF FARICIMAB AND AFLIBERCEPT IN DIABETIC MACULAR EDEMA, A SYSTEMATIC REVIEW” (2025) Frontier in Medical and Health Research, 3(9), pp. 782–795. Available at: https://fmhr.net/index.php/fmhr/article/view/1649 (Accessed: 16 April 2026).